These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15276667)

  • 1. Prevalence of induced mania in patients treated with milnacipran: a comparison with paroxetine.
    Morishita S; Arita S
    Eur Psychiatry; 2004 Aug; 19(5):315-6. PubMed ID: 15276667
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
    Morishita S; Arita S
    Eur Psychiatry; 2003 Dec; 18(8):418-20. PubMed ID: 14680720
    [No Abstract]   [Full Text] [Related]  

  • 3. Paroxetine-induced mania.
    Oldroyd J
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):721-2. PubMed ID: 9183122
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of milnacipran and paroxetine on overactive bladder due to neurologic diseases: a urodynamic assessment.
    Sakakibara R; Ito T; Uchiyama T; Awa Y; Yamaguchi C; Hattori T
    Urol Int; 2008; 81(3):335-9. PubMed ID: 18931554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.
    Vandel P; Sechter D; Weiller E; Pezous N; Cabanac F; Tournoux A; Panconi E
    Hum Psychopharmacol; 2004 Dec; 19(8):585-6. PubMed ID: 15570574
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential effects of milnacipran, fluvoxamine and paroxetine for inhibited and agitated depression.
    Morishita S; Arita S
    Eur Psychiatry; 2004 Nov; 19(7):450-1. PubMed ID: 15504656
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of milnacipran and paroxetine in outpatients with major depression.
    Sechter D; Vandel P; Weiller E; Pezous N; Cabanac F; Tournoux A;
    J Affect Disord; 2004 Dec; 83(2-3):233-6. PubMed ID: 15555719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep disturbance associated with an enhanced orexinergic system induced by chronic treatment with paroxetine and milnacipran.
    Rahmadi M; Narita M; Yamashita A; Imai S; Kuzumaki N; Suzuki T
    Synapse; 2011 Jul; 65(7):652-7. PubMed ID: 21157932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients.
    Yoshimura R; Mitoma M; Sugita A; Hori H; Okamoto T; Umene W; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1034-7. PubMed ID: 17459550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age.
    Morishita S; Arita S
    Hum Psychopharmacol; 2004 Aug; 19(6):405-8. PubMed ID: 15303244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSRI-induced mania.
    Grubbs JH
    J Am Acad Child Adolesc Psychiatry; 1997 Apr; 36(4):445. PubMed ID: 9100415
    [No Abstract]   [Full Text] [Related]  

  • 12. Lower side effects of milnacipran than paroxetine in the treatment of major depression disorder among Han Chinese in Taiwan.
    Chang TT; Lêng CH; Wu JY; Lee SY; Wang YS; Chen YC; Lu RB
    Chin J Physiol; 2008 Dec; 51(6):387-93. PubMed ID: 19280883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raynaud's syndrome in a patient treated with milnacipran.
    Bourgade B; Jonville-Béra AP; Le Garé C; Ferquel D; Autret-Leca E
    Ann Pharmacother; 1999 Sep; 33(9):1009-10. PubMed ID: 10492510
    [No Abstract]   [Full Text] [Related]  

  • 14. Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression.
    Kurose K; Hiratsuka K; Ishiwata K; Nishikawa J; Nonen S; Azuma J; Kato M; Wakeno M; Okugawa G; Kinoshita T; Kurosawa T; Hasegawa R; Saito Y
    Psychiatry Res; 2012 Aug; 198(3):424-9. PubMed ID: 22445761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of selective serotonin reuptake inhibitor-induced sexual dysfunction without worsening of depressive symptom after switching to milnacipran.
    Takahashi H; Ishigooka J
    Clin Neuropharmacol; 2009; 32(3):177-8. PubMed ID: 19483494
    [No Abstract]   [Full Text] [Related]  

  • 16. SSRI-induced mania in obsessive-compulsive disorder.
    Diler RS; Avci A
    J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):6-7. PubMed ID: 9893408
    [No Abstract]   [Full Text] [Related]  

  • 17. Mania associated with serotonin selective reuptake inhibitors.
    Vesely C; Fischer P; Goessler R; Kasper S
    J Clin Psychiatry; 1997 Feb; 58(2):88. PubMed ID: 9062382
    [No Abstract]   [Full Text] [Related]  

  • 18. Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study.
    Patel R; Reiss P; Shetty H; Broadbent M; Stewart R; McGuire P; Taylor M
    BMJ Open; 2015 Dec; 5(12):e008341. PubMed ID: 26667012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of severe antidepressant-induced nausea with a combination of milnacipran and olanzapine.
    Yoshida K; Higuchi H; Ozaki N
    Pharmacopsychiatry; 2007 Mar; 40(2):84-5. PubMed ID: 17447181
    [No Abstract]   [Full Text] [Related]  

  • 20. [Probable Serotonin Syndrome and Withdrawal Symptoms Caused by Milnacipran].
    Koshiishi T; Okuyama K
    Yakugaku Zasshi; 2016; 136(12):1675-1679. PubMed ID: 27904101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.